Warner Chilcott and Mayne file patent infringement lawsuit against Sandoz
WCRX | Quote | Chart | News | PowerRating -- Warner Chilcott, a specialty pharmaceutical company, has announced that one of its subsidiaries and Mayne Pharma International, a subsidiary of Hospira, have filed a lawsuit against Sandoz in the District Court of New Jersey for infringement of Mayne's US patent which covers Doryx, a tetracycline-class oral antibiotic.
The lawsuit is in response to the submission of an abbreviated new drug application to the FDA by Sandoz requesting approval to manufacture and sell generic versions of Doryx 100 and 75mg delayed-release tablets prior to the expiration in 2022 of the patent. Warner Chilcott and Mayne intend to vigorously defend the patent and pursue their legal rights.
Warner Chilcott markets and sells Doryx delayed-release tablets in 150, 100 and 75mg strengths under a licensing agreement with Mayne. Warner Chilcott previously announced the filing of similar lawsuits against each of Mutual Pharmaceutical Company, Mylan Pharmaceuticals and Impax Laboratories on December 23, 2008.
http://www.datamonitor.com
Republication or redistribution, including by framing or similar means,
is expressly prohibited without prior written consent. Datamonitor shall
not be liable for errors or delays in the content, or for any actions
taken in reliance thereon
For full details on Warner Chilcott Ltd Cl A (WCRX) WCRX. Warner Chilcott Ltd Cl A (WCRX) has Short Term PowerRatings at TradingMarkets. Details on Warner Chilcott Ltd Cl A (WCRX) Short Term PowerRatings is available at This Link.
For full details on (SDOZY) SDOZY. (SDOZY) has Short Term PowerRatings at TradingMarkets. Details on (SDOZY) Short Term PowerRatings is available at This Link.
- Warner Chilcott Provides Mixed Guidance - 01/29/10
- Warner Chilcott Announces 2010 Financial Guidance - 01/29/10
- Analyst Downgrades for January 28th - 01/28/10
- Warner Chilcott obtains FDA complete response letter for contraception drug - 01/28/10
- FDA Issues Complete Response Letter for Low Dose Oral Contraceptive - 01/27/10
- More News >>


